Publications by authors named "Shidi Xu"

Claim this Profile
M
Mapping the Treatment Journey of Children on Subcutaneous House Dust Mite Immunotherapy: A Qualitative Study.
Shidi Xu, Zhujun Gu, Jie Zhao, Jiehua Xu, Jun Xie

J Multidiscip Healthc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present).
Yufeng An, Xinya Lv, Shidi Xu, Heqing Li, Pengwu Zheng

Eur J Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing 5-(3,5-difluorobenzyl)-1H-indazole as the active pharmacophore of ALK/ROS1 dual inhibitors through theoretical calculations and biological activity evaluations.
Xiaoling Huang, Shidi Xu, Yufeng An, Xinya Lv, Lulu Tian, Shan Xu

Bioorg Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020-present.
Xiaoling Huang, Shidi Xu, Lei Duan, Shan Xu, Wufu Zhu

Expert Opin Ther Pat· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFR and EGFR.
Linxiao Wang, Xiaoling Huang, Shidi Xu, Yufeng An, Xinya Lv, Shan Xu

BMC Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Overcoming EGFR Mutation: A Perspective on the 2-Aryl-4-aminothienopyrimidine Backbone.
Xuan Zhang, Jie He, Shidi Xu, Li Fu, Pengwu Zheng, Shan Xu

ChemMedChem· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel bioactive 2-phenyl-4-aminopyrimidine derivatives as EGFR inhibitors for the treatment of non-small cell lung cancer.
Shidi Xu, Zhihui Zhou, Jie He, Jiaojiao Guo, Xiaoling Huang, Shan Xu

Arch Pharm (Weinheim)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of dual electronic cigarettes and marijuana use with sleep duration among adults from the United States, NHANES 2015-2018.
Zhenzhen Pan, Qian Wang, Yun Guo, Shidi Xu, Shanshan Pan, Shiyao Xu

Prev Med Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrole-based EGFR inhibitors for the treatment of NCSLC: Binding modes and SARs investigations.
Jie He, Leixuan Luo, Shidi Xu, Feiyi Yang, Wufu Zhu

Chem Biol Drug Des· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis